Evidence map›Paper›PMID 26888209›Full record

ArticleBMJ (Clinical research ed.)2016

Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers.

Ruijun Chen, Nihar R Desai, Joseph S Ross, Weiwei Zhang, Katherine H Chau, Brian Wayda, Karthik Murugiah, Daniel Y Lu, Amit Mittal, Harlan M Krumholz

Open access · hybridAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 8 pooled it
32.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 8 syntheses or guidelines pooled it, 239 citations in OpenAlex.

  1. Pooled it
  2. Time to publication for results of clinical trials.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Determinants of publication likelihood and timeliness for clinical studies.Journal of clinical and translational science · 2026
    Article
  18. Article
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Ruijun ChenDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Nihar R DesaiSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT 06510, USA.
Joseph S RossCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT 06510, USA Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.
Weiwei ZhangCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT 06510, USA.
Katherine H ChauDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Brian WaydaDivision of General Medicine, Department of Internal Medicine, Columbia University Medical Center, New York, NY, USA.
Karthik MurugiahDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Daniel Y LuDepartment of Medicine, University of Pennsylvania Health System, Philadelphia, PA, USA.
Amit MittalDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Harlan M KrumholzSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT 06510, USA Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA harlan.krumholz@yale.edu.
Yale University · USUniversity of California, San Francisco · USYale New Haven Hospital · USColumbia University Irving Medical Center · USRobert Wood Johnson Foundation · USUniversity of Pennsylvania Health System · US

Funding

Center for Cardiovascular Outcomes Research at Yale UniversityU01HL105270 · NHLBI · YALE UNIVERSITY · PI CURTIS, JEPTHA PELHAM, KRUMHOLZ, HARLAN MARC · 2010 to 2013
$5.8M
Yale-CORE Career Development Program in Patient-Centered Outcomes ResearchK12HS023000 · AHRQ · YALE UNIVERSITY · PI KRUMHOLZ, HARLAN MARC · 2014 to 2018
$3.4M
Impact of Publicity Reporting Hospital Outcome Measures for Older AdultsK08AG032886 · NIA · YALE UNIVERSITY · PI ROSS, JOSEPH SOLOMON · 2008 to 2012
$738k
AHRQ HHS K12 HS023000-01NHLBI NIH HHS U01 HL105270-05NIA NIH HHS K08 AG032886
6 · The paper itself

Abstract

objectiveTo determine rates of publication and reporting of results within two years for all completed clinical trials registered in ClinicalTrials.gov across leading academic medical centers in the United States.

designCross sectional analysis.

settingAcademic medical centers in the United States.

participantsAcademic medical centers with 40 or more completed interventional trials registered on ClinicalTrials.gov.

methodsUsing the Aggregate Analysis of ClinicalTrials.gov database and manual review, we identified all interventional clinical trials registered on ClinicalTrials.gov with a primary completion date between October 2007 and September 2010 and with a lead investigator affiliated with an academic medical center.

main outcome measuresThe proportion of trials that disseminated results, defined as publication or reporting of results on ClinicalTrials.gov, overall and within 24 months of study completion.

resultsWe identified 4347 interventional clinical trials across 51 academic medical centers. Among the trials, 1005 (23%) enrolled more than 100 patients, 1216 (28%) were double blind, and 2169 (50%) were phase II through IV. Overall, academic medical centers disseminated results for 2892 (66%) trials, with 1560 (35.9%) achieving this within 24 months of study completion. The proportion of clinical trials with results disseminated within 24 months of study completion ranged from 16.2% (6/37) to 55.3% (57/103) across academic medical centers. The proportion of clinical trials published within 24 months of study completion ranged from 10.8% (4/37) to 40.3% (31/77) across academic medical centers, whereas results reporting on ClinicalTrials.gov ranged from 1.6% (2/122) to 40.7% (72/177).

conclusionsDespite the ethical mandate and expressed values and mission of academic institutions, there is poor performance and noticeable variation in the dissemination of clinical trial results across leading academic medical centers.

Indexed as

Clinical Trials as TopicAcademic Medical CentersCross-Sectional StudiesDatabases, FactualHumansPublishingUnited States

Identifiers

PMID26888209
PMCPMC4768882
OpenAlexW2277874940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.